Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.43 |
| ▸ | CTSV | O60911 | 3/20 | 0.42 |
| ▸ | CTSL | P07711 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
| ▸ | MAX | P61244 | 1/20 | 0.39 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518325 | 1.00 | MEN1 (0.48) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL6514763 | 0.86 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL7031532 | 0.85 | MEN1 (0.52) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL7031531 | 0.85 | MEN1 (0.52) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL7031530 | 0.85 | MEN1 (0.52) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL121875 | 0.84 | CYP3A4 (0.47) | MEN1KMT2AALDH1A1MAPTPOLB | |
| SCHEMBL7031522 | 0.84 | ALDH1A1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL7031518 | 0.84 | ALDH1A1 (0.50) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL31756984 | 0.81 | MEN1 (0.56) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL10585706 | 0.81 | MEN1 (0.56) | MEN1KMT2AALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6489466-B2 | PRODUCING IMMOBILIZED OLIGONUCLEOTIDES ON A SUBSTRATE BY COVALENTLY ATTACHING A FIRST NUCLEOTIDE OR OLIGONUCLEOTIDE VIA A C-5' OXYGEN OF THE NUCLEOTIDE TO THE SUBSTRATE; C-3'OXYGEN PROTECTED WITH PHOTO- OR CHEMICAL-LABILE GROUPS | LINDEN TECHNOLOGIES, INC. | 2002-12-03 | — | — | US | claimed |
| US-6855501-B2 | Transfer of arrayed chemical compositions | LINDEN TECHNOLOGIES, INC. (US) | 2005-02-15 | — | — | US | disclosed |
| US-6838447-B2 | Particulate compositions for chemical synthesis | LINDEN TECHNOLOGIES, INC. (US) | 2005-01-04 | — | — | US | disclosed |
| US-20040013573-A1 | Polymer synthesis apparatus | LINDEN TECHNOLOGIES, INC. | 2004-01-22 | — | — | US | disclosed |
| US-20030013868-A1 | C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support | LINDEN TECHNOLOGIES, INC., A DELAWARE CORPORATION | 2003-01-16 | — | — | US | disclosed |
| US-20030009027-A1 | C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support | LINDEN TECHNOLOGIES, INC., A DELAWARE CORPORATION | 2003-01-09 | — | — | US | disclosed |
| US-6489466-B2 | PRODUCING IMMOBILIZED OLIGONUCLEOTIDES ON A SUBSTRATE BY COVALENTLY ATTACHING A FIRST NUCLEOTIDE OR OLIGONUCLEOTIDE VIA A C-5' OXYGEN OF THE NUCLEOTIDE TO THE SUBSTRATE; C-3'OXYGEN PROTECTED WITH PHOTO- OR CHEMICAL-LABILE GROUPS | LINDEN TECHNOLOGIES, INC. | 2002-12-03 | — | — | US | disclosed |
| US-20020168669-A1 | Patterned polymer synthesis | LINDEN TECHNOLOGIES, INC. | 2002-11-14 | — | — | US | disclosed |
| US-20020136772-A1 | Polymer synthesis | LINDEN TECHNOLOGIES, INC. | 2002-09-26 | — | — | US | disclosed |
| US-20020137719-A1 | Particulate compositions for chemical synthesis | LINDEN TECHNOLOGIES, INC. | 2002-09-26 | — | — | US | disclosed |
| US-20020136978-A1 | Transfer of arrayed chemical compositions | LINDEN TECHNOLOGIES, INC. | 2002-09-26 | — | — | US | disclosed |
| US-20010044530-A1 | C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support | LINDEN TECHNOLOGIES, INC. | 2001-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030013868-A1 | C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support | RNGTT, BCDIN3D, NT5C3B | MEN1 2595/4885KMT2A 2885/4885ALDH1A1 3128/4885 |
| US-20010044530-A1 | C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support | RNGTT, BCDIN3D, NT5C3B | MEN1 2595/4885KMT2A 2885/4885ALDH1A1 3128/4885 |
| US-20030009027-A1 | C-3' protected monomeric nucleotides and synthesis of oligonucleotides on solid support | RNGTT, BCDIN3D, NT5C3B | MEN1 2595/4885KMT2A 2885/4885ALDH1A1 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.